# Venmedtech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/venmedtech

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Total disclosed funding: $15M
- Latest round: Series B (Oct 25, 2022)
- Investors on record: 9

## About

Based in Suzhou, China and established in 2016, Suzhou Tianhong Shengjie Medical Equipment Co., Ltd., trading as Venmedtech, is a medical company that focuses on developing venous vascular disease treatment products. As of 2022, it has applied for 55 domestic patents and granted 40. In May 2026, Venmedtech raised a venture funding from Chuangjing Capital.

The company engages in research and development of venous vascular disease treatment products. Its main products include iliac vein stent systems, peripheral balloon dilatation catheters, peripheral vascular high pressure balloon dilatation catheters, intravascular foreign body removal devices, saphenous vein stripping catheters and balloon inflation devices.

The company's revenue is generated by providing venous vascular disease treatment products.

The company will use the latest funding to continuously strengthen its core technology barriers in peripheral venous intervention, accelerate the R&D and commercialization of innovative pipelines such as peripheral arteries and tumor embolization, deepen its "devices + materials + supply chain" full-industry chain layout, and lead the domestic substitution and globalization process of peripheral interventional devices both domestically and internationally.

## Funding rounds

- Series B, Oct 25, 2022 — Qiaojing Capital, Suzhou Zhuopu Fund Management
- Series B, Apr 20, 2021, $15M — Wuxi Guolian Industrial Investment Private Equity Fund Management, SND Ventures Group, Lotus Lake Capital, Purple Cow Startups, Greenriver Capital
- Series A, Apr 3, 2020 — SND Ventures Group, Greenriver Capital
- Series A, Oct 25, 2017 — Shanghai China Healthcare Venture Management
- Angel, Jun 30, 2016 — Tririver Capital

## Investors

- Tririver Capital (https://capitalatlas.ai/funds/tririver-capital) — Angel
- Shanghai China Healthcare Venture Management (https://capitalatlas.ai/funds/shanghai-china-healthcare-venture-management) — Series A
- SND Ventures Group (https://capitalatlas.ai/funds/snd-ventures-group) — Series A, Series B
- Greenriver Capital (https://capitalatlas.ai/funds/greenriver-capital) — Series A, Series B
- Wuxi Guolian Industrial Investment Private Equity Fund Management — Series B
- Lotus Lake Capital (https://capitalatlas.ai/funds/lotus-lake-capital) — Series B
- Purple Cow Startups (https://capitalatlas.ai/funds/purple-cow-startups) — Series B
- Qiaojing Capital (https://capitalatlas.ai/funds/qiaojing-capital) — Series B
- Suzhou Zhuopu Fund Management — Series B